Concepedia
Statistics
Publications
9
Citations
669
H-Index
Active since
1997
Affiliations
Stanford University(Current)
Henry Ford Hospital
Stanford Blood Center
John F. Kennedy Medical Center
University of California San Diego
Dawn Gammon is an author at Stanford University specializing in medicine, oncology, and pharmacology.
Publications per year
1997–2020
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F. Cloughesy, Joseph Landolfi, Daniel J. Hogan et al. · Science Translational Medicine · 2016 · 199 citations · Full text
Medicine, Oncology, Pharmacology +16
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
Timothy F. Cloughesy, Joseph Landolfi, Michael A. Vogelbaum et al. · Neuro-Oncology · 2018 · 176 citations · Full text
CTL Response to <i>Mycobacterium tuberculosis</i> : Identification of an Immunogenic Epitope in the 19-kDa Lipoprotein
Nahid Mohagheghpour, Dawn Gammon, L. Masae Kawamura et al. · The Journal of Immunology · 1998 · 112 citations · Full text
Life Sciences, Immunology, Infectious Diseases +17
EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE
Christopher D. Herzog, Lamar Brown, Dawn Gammon et al. · Neurosurgery · 2009 · 75 citations
Life Sciences, Neurobiology, Neuroscience +17
Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients
Daniel J. Hogan, Jay‐Jiguang Zhu, Oscar R. Diago et al. · Clinical Cancer Research · 2018 · 33 citations
Medicine, Oncology, Pharmacology +14
1–5 of 9